Exafib 15 Tablet
Marketer
Emcure Pharmaceuticals Ltd
Salt Composition
Rivaroxaban (15mg)
Overview Exafib 15 Tablet
CardioGuard 15mg tablets are an anticoagulant medication, acting as a blood thinner. This medication prevents and treats blood clots, thereby lowering the risk of stroke and heart attack. It's effective in preventing clot formation in leg, lung, brain, and heart veins. CardioGuard 15mg is frequently prescribed for individuals with atrial fibrillation to prevent clot formation, and also for those recovering from knee or hip replacements to minimize clotting risk. It can be taken with or without food, consistently at the same time daily for optimal efficacy. Long-term use, potentially lifelong, may be necessary. Never discontinue or adjust the dosage without consulting your physician; abrupt cessation significantly increases the risk of stroke, heart attack, or thrombosis. Lifestyle modifications, including smoking cessation, healthy eating, regular exercise, and weight management (if needed), further reduce clotting risk. Increased bleeding (e.g., nosebleeds, easy bruising) is a common side effect; report any unusual symptoms immediately to your doctor. This medication is contraindicated for patients with severe kidney or liver disease, active bleeding, or concurrent use of other anticoagulants. Breastfeeding is not recommended while taking CardioGuard 15mg. Unlike some other anticoagulants, routine PT-INR blood monitoring isn't required.
Primary Ingredients of Exafib 15 Tablet
No text provided to rephrase.
Uses of Exafib 15 Tablet
Preventing and managing blood clots
Major Benefits of Exafib 15 Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Exafib 15 Tablet can be consumed with or without food, however, consistent daily timing is recommended.
Common Side effects of Exafib 15 Tablet:
- Bleeding
How to use Exafib 15 Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Exafib 15 Tablet can be consumed with or without food, although consistent timing is recommended.
How Exafib 15 Tablet works:
Xafib 15mg tablets represent a new class of oral blood thinners. Their mechanism involves the inhibition of factor Xa, a key clotting agent, thus reducing the likelihood of blood clot development.
SAFETY ADVICE
AlcoholCAUTION
Use of Exafib 15 Tablet with alcohol requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Exafib 15 Tablet during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Use of Exafib 15 Tablet while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Driving may be impaired by Exafib 15 Tablet, which can induce dizziness or fainting. These side effects could negatively impact your ability to operate a vehicle.
KidneyCAUTION
Patients with kidney impairment should use Exafib 15 Tablet cautiously, potentially requiring dosage modification. Physician consultation is advised. Exafib 15 Tablet is contraindicated in individuals with severe kidney disease.
LiverUNSAFE
The use of Exafib 15 Tablet is likely inadvisable for individuals with hepatic impairment and should be avoided. Medical advice is recommended.
What if you forget to take Exafib 15 Tablet :
Should you forget a dose of Exafib 15 Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Exafib 15 Tablet
| Label | Value |
|---|---|
| Chemical Type | Morpholine-thiophene derivatives |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Action Category | Xa Inhibitors (Oral) |





